研究者業績

中江 俊介

Shunsuke Nakae

基本情報

所属
藤田医科大学 医学部 医学科 脳神経外科学 准教授
学位
医学博士(藤田医科大学)
Master of Science(San Diego State University)

J-GLOBAL ID
201501021123484677
researchmap会員ID
7000012929

論文

 38
  • Masanobu Kumon, Shunsuke Nakae, Daijiro Kojima, Noeru Kawase, Yuichi Hirose
    Acta Neurochirurgica 167(1) 2025年8月26日  査読有り責任著者
    Abstract The lateralized efficacy of vagus nerve stimulation (VNS) remains insufficiently explored. We report a case of drug-resistant epilepsy with bilateral frontal lobe seizure onset, treated with left cervical VNS. Preoperative video- electroencephalogram revealed predominant interictal discharges in the right hemisphere and frequent seizures from both hemispheres. Following VNS, overall seizure frequency decreased. Notably, stereo-electroencephalography performed 15 months postoperatively showed a marked reduction in right-sided seizures, while left-sided seizures remained frequent. This case highlights the potential lateralized effect of VNS in a single patient with bilateral frontal lobe epilepsy, suggesting that VNS may preferentially suppress seizures originating from the right hemisphere.
  • Masanobu Kumon, Shunsuke Nakae, Shigeo Ohba, Masato Abe, Seiji Yamada, Hikaru Sasaki, Takema Kato, Hiroki Kurahashi, Yuichi Hirose
    Brain Tumor Pathology 2025年7月27日  査読有り責任著者
  • Noeru Kawase, Shunsuke Nakae, Masanobu Kumon, Motoharu Hayakawa, Chiaki Shinzato, Yuriko Sato, Takehiro Uda, Takumi Mitsuhashi, Masaki Fukunaga, Shigeo Ohba, Yuichi Hirose
    Frontiers in Human Neuroscience 19 2025年7月17日  査読有り責任著者
    Posterior Quadrant Disconnection is a surgical technique designed to suppress seizure propagation while preserving motor and sensory functions in patients with drug-resistant epilepsy. Although seizure outcomes following this procedure have been reported, detailed evaluations of its impact on higher cognitive functions remain limited. This study aimed to assess the long-term seizure and cognitive outcomes following PQD in the non-dominant hemisphere, thereby evaluating the efficacy and safety of the procedure. In this case, the patient with drug-resistant epilepsy underwent preoperative evaluation using stereo electroencephalography (SEEG) to identify seizure onset zones and functional mapping related to visuospatial cognition. Following this assessment, PQD was performed. Postoperative outcomes were monitored over a 2-years period, focusing on seizure control and higher cognitive function. The patient achieved Engel class I status postoperatively, indicating complete seizure cessation. While transient hemispatial neglect was observed immediately after surgery, gradual improvement was noted over time. Furthermore, visual memory and cognitive functions showed a tendency to improve, and there were no significant declines in facial recognition or scene recognition abilities. These findings suggest that PQD can effectively improve seizure outcomes while minimizing long-term impacts on cognitive functions. This case highlights the potential of PQD to offer substantial seizure control with limited permanent effects on higher cognitive functions. By providing valuable insights into the safety and efficacy of PQD in the non-dominant hemisphere, this study underscores its viability as a treatment option for selected cases of drug-resistant epilepsy.
  • Shigeo Ohba, Takao Teranishi, Kazuyasu Matsumura, Masanobu Kumon, Daijiro Kojima, Eiji Fujiwara, Kazutaka Nakao, Kiyonori Kuwahara, Kazuhiro Murayama, Eriel Sandika Pareira, Seiji Yamada, Masahiro Joko, Shunsuke Nakae, Jun Muto, Yuya Nishiyama, Kazuhide Adachi, Hikaru Sasaki, Masato Abe, Mitsuhiro Hasegawa, Yuichi Hirose
    Scientific reports 15(1) 1750-1750 2025年1月11日  査読有り
    Karnofsky Performance Status (KPS) is a widely used scale to assess performance status. KPS ≥ 50% implies that patients can live at home. Therefore, maintaining KPS ≥ 50% is important to improve the quality of life of patients with glioblastoma, whose median survival is less than 2 years. This study aimed to identify the factors associated with survival time with maintenance of KPS ≥ 50% (survival with KPS ≥ 50%) in patients with glioblastoma, IDH-wildtype. Ninety-eight patients with glioblastomas, IDH-wildtype, who were treated with concomitant radiotherapy (RT) and temozolomide (TMZ) followed by maintenance TMZ therapy, and whose KPS at the start of RT was ≥ 50%, were included. The median survival with KPS ≥ 50% was 13.3 months. In univariate analysis, preoperative KPS (≥ 80%), KPS at the start of RT (≥ 80%), residual tumor size (< 2 cm3), methylated MGMT promotor, and implantation of BCNU wafer were associated with survival with KPS ≥ 50%. In multivariate analysis, KPS at the start of RT (≥ 80%), methylated MGMT promotor, and residual tumor size (< 2 cm3) were significantly associated with increased survival with KPS ≥ 50%. A strategy of maximum possible tumor resection without compromising KPS is desirable to prolong the survival time with KPS ≥ 50%.
  • Koji Ohyama, Shunsuke Nakae, Yuki Uehara
    Infection 2024年6月10日  査読有り
  • Shunsuke Nakae, Masanobu Kumon, Takao Teranishi, Shigeo Ohba, Yuichi Hirose
    Brain Sciences 13(3) 482-482 2023年3月13日  査読有り筆頭著者責任著者
    Fence-post catheter techniques are used to use tumor margins when resecting gliomas. In the present study, deep electrodes instead of catheters were used as fence-posts. The case of a 25-year-old female patient whose magnetic resonance images (MRI) revealed a tumor in the left cingulate gyrus is presented in this study. She underwent daily seizures without loss of consciousness under the administration of anti-seizure medications. Despite video electroencephalography (EEG) monitoring, the scalp inter-ictal EEG did not show obvious epileptiform discharges. We were consequently uncertain whether such frequent seizures were epileptic seizures or not. As a result, deep electrodes were used as fence-posts: three deep electrodes were inserted into the tumor’s anterior, lateral, and posterior margins using a navigation-guided method. The highest epileptic discharge was detected from the anterior deep electrode. As a result, ahead of the tumor was extendedly resected, and epileptic discharges were eliminated using EEG. The postoperative MRI revealed that the tumor was resected. The patient has never experienced seizures after the surgery. In conclusion, when supratentorial gliomas complicated by frequent seizures are resected, intraoperative EEG monitoring using deep electrodes as fence-posts is useful for estimating epileptogenic areas.
  • Shunsuke Nakae, Masanobu Kumon, Akio Katagata, Kazuhiro Murayama, Yuichi Hirose
    Brain Sciences 13(3) 396-396 2023年2月25日  査読有り筆頭著者責任著者
    Vagus nerve stimulation (VNS) is an effective surgical option for intractable epilepsy. Although the surgical procedure is not so complicated, vagus nerve detection is sometimes difficult due to its anatomical variations, which may lead to surgical manipulation-associated complications. Thus, this study aimed to visualize the vagus nerve location preoperatively by fused images of three-dimensional computed tomography angiography (3D-CTA) and magnetic resonance imaging (MRI). This technique was applied to two cases. The neck 3D-CTA and MRI were performed, and the fused images were generated using the software. The vagus nerve and its anatomical relationship with the internal jugular vein (IJV) and common carotid artery were clearly visualized. The authors predicted that the vagus nerve was detected by laterally pulling the IJV according to the images. Intraoperatively, the vagus nerve was located as the authors predicted. The time of the surgery until the vagus nerve detection was &lt;60 min in both cases. This novel radiological technique for visualizing the vagus nerve is effective to quickly detect the vagus nerve, which has anatomical variations, during the VNS.
  • Shigeo Ohba, Kazuhiro Murayama, Takao Teranishi, Masanobu Kumon, Shunsuke Nakae, Masao Yui, Kaori Yamamoto, Seiji Yamada, Masato Abe, Mitsuhiro Hasegawa, Yuichi Hirose
    Cancers 15(3) 952-952 2023年2月2日  査読有り
    Distinguishing primary central nervous system lymphoma (PCNSL) from glioblastoma, isocitrate dehydrogenase (IDH)-wildtype is sometimes hard. Because the role of operation on them varies, accurate preoperative diagnosis is crucial. In this study, we evaluated whether a specific kind of chemical exchange saturation transfer imaging, i.e., amide proton transfer-weighted (APTw) imaging, was useful to distinguish PCNSL from glioblastoma, IDH-wildtype. A total of 14 PCNSL and 27 glioblastoma, IDH-wildtype cases were evaluated. There was no significant difference in the mean APTw signal values between the two groups. However, the percentile values from the 1st percentile to the 20th percentile APTw signals and the width1–100 APTw signals significantly differed. The highest area under the curve was 0.796, which was obtained from the width1–100 APTw signal values. The sensitivity and specificity values were 64.3% and 88.9%, respectively. APTw imaging was useful to distinguish PCNSL from glioblastoma, IDH-wildtype. To avoid unnecessary aggressive surgical resection, APTw imaging is recommended for cases in which PCNSL is one of the differential diagnoses.
  • Shunsuke Nakae, Masanobu Kumon, Daijiro Kojima, Saeko Higashiguchi, Shigeo Ohba, Naohide Kuriyama, Yuriko Sato, Yoko Inamoto, Masahiko Mukaino, Yuichi Hirose
    Journal of Neurosurgery: Case Lessons 3(5) 2022年1月31日  査読有り筆頭著者責任著者
    <sec> <title>BACKGROUND</title> A common surgical approach for dominant insular lesions is to make a surgical corridor in asymptomatic cortices based on functional mapping. However, the surgical approach is difficult for posterior insular lesions in a dominant hemisphere because the posterior parts of the perisylvian cortices usually have verbal functions. </sec> <sec> <title>OBSERVATIONS</title> We present the case of a 40-year-old male whose magnetic resonance images revealed the presence of contrast-enhancing lesions in the left posterior insula. Our surgical approach was to split the sylvian fissure as widely as possible, and partially resect Heschl’s gyrus if the cortical mapping was negative for language tests. Because Heschl’s gyrus did not have verbal functions, the gyrus was used as a surgical corridor. It was wide enough for the removal of the lesion; however, because intraoperative pathological diagnosis eliminated the possibility of brain tumors, further resection was discontinued. The tissues were histologically diagnosed as tuberculomas. Antituberculosis drugs were administered, and the residual lesions finally disappeared. According to the neurophysiological tests, the patient showed temporary impairment of auditory detection, but the low scores of these tests improved. </sec> <sec> <title>LESSONS</title> The transsylvian and trans-Heschl’s gyrus approach can be a novel surgical option for excising dominant posterior insular lesions. </sec>
  • Yushi Kawazoe, Shigeo Ohba, Kazuhiro Murayama, Shunsuke Nakae, Yuya Nishiyama, Masato Abe, Mitsuhiro Hasegawa, Yuichi Hirose
    World neurosurgery 158 e820-e828 2021年11月20日  査読有り
    BACKGROUND: We investigated the ability of magnetic resonance imaging (MRI) to distinguish primary central nervous system vasculitis (PCNSV) from glioblastoma to facilitate the development of an appropriate treatment for PCNSV. METHODS: We enrolled patients who were treated for PCNSV or glioblastoma at our center between January 2007 and August 2018. We compared the diagnoses of the 2 conditions by retrospectively reviewing patients' data for contrast-enhanced MRI, perfusion MRI, flow-sensitive black-blood (FSBB) imaging, and 1H-magnetic resonance spectroscopy (MRS). RESULTS: We evaluated 108 patients (6 PCNSV; 102 glioblastoma). We found a statistically significant correlation between diagnosis and the contrast pattern on MRI. Perivascular enhancement was observed in all cases of PCNSV as follows: ring-like, homogeneous, and irregular patterns were observed in 53 (60%), 18 (20%), and 17 (19%) cases of glioblastoma, respectively. We identified a statistically significant correlation between diagnosis and cerebral blood volume (CBV) in 3 patients with PCNSV who underwent perfusion MRI; and all had low CBVs. Among the 55 patients with glioblastoma who underwent perfusion MRI, low and high CBVs were detected in 3 and 52 patients, respectively. There was no significant correlation between diagnosis and FSBB findings. Evaluation of 1H-MRS data showed statistically significant differences between PCNSV and glioblastoma as functions of neuronal amino acid levels on long echo time MRS, with a slightly different amino acid profile, including glutamine + glutamate on short echo time MRS. CONCLUSIONS: Contrast-enhanced MRI, perfusion MRI, and quantitative analysis of 1H-MRS are valuable techniques for distinguishing PCNSV from glioblastoma before surgery.
  • Joji Inamasu, Masashi Nakatsukasa, Shunsuke Nakae
    Acute Medicine & Surgery 8(1) 2021年1月  査読有り
  • Shunsuke NAKAE, Masanobu KUMON, Shigeta MORIYA, Shinichiro TATEYAMA, Yushi KAWAZOE, Kei YAMASHIRO, Joji INAMASU, Yuichi HIROSE
    Neurologia medico-chirurgica 61(10) 570-576 2021年  査読有り筆頭著者責任著者
    Seizures are common neurological emergencies that occasionally cause prolonged impairment of consciousness. The aim of this retrospective single-center study is to clarify factors associated with prolonged impairment of consciousness for admitted adult patients investigating patient backgrounds, blood tests, electroencephalographic patterns, and MRI findings. The patients who were admitted to the hospital due to epileptic seizures were classified into two groups: (1) early recovery group, in which patients recovered their consciousness within 6 hr, and (2) delayed recovery group, in which patients showed impairment of consciousness more than 6 hr. Factors associated with prolonged impairment of consciousness were compared between these groups. In this study, 42 cases (33 patients), with a mean age of 67.8 years, were included. Fifteen cases (13 patients) and 27 cases (20 patients) were classified into the early and delayed recovery groups, respectively. The populations of older patients and patients from a nursing home were significantly higher in the delayed recovery group. With regard to radiological analyses, a high grade of periventricular hyperintensity (PVH), high Evans index score, and enlarged bilateral atrial widths were significantly associated with prolonged impairment of consciousness. Multivariable analyses showed that a high grade of PVH was significantly associated with delayed recovery of consciousness independent of age and status epilepticus. In conclusion, we proposed that diffuse white matter degeneration around the lateral ventricles contributes to prolonged impairment of consciousness.
  • Masanobu KUMON, Shunsuke NAKAE, Kazuhiro MURAYAMA, Takema KATO, Shigeo OHBA, Joji INAMASU, Seiji YAMADA, Masato ABE, Hikaru SASAKI, Yoshiharu OHNO, Mitsuhiro HASEGAWA, Hiroki KURAHASHI, Yuichi HIROSE
    Neurologia medico-chirurgica 61(8) 453-460 2021年  査読有り責任著者
    Isocitrate dehydrogenase (IDH) wild-type diffuse astrocytic tumors tend to be pathologically diagnosed as glioblastomas (GBMs). We previously reported that myoinositol to total choline (Ins/Cho) ratio in GBMs on magnetic resonance (MR) spectroscopy was significantly lower than that in IDH-mutant gliomas. We then hypothesized that a low Ins/Cho ratio is a poor prognosis factor in patients with GBMs, IDH-wild-type. In the present study, we calculated the Ins/Cho ratios of patients with GBMs and investigated their progression-free survival (PFS) and overall survival (OS) to determine their utility as prognostic marker. We classified patients with GBMs harboring wild-type IDH (n = 27) into two groups based on the Ins/Cho ratio, and compared patient backgrounds, pathological findings, PFS, OS, and copy number aberrations between the high and low Ins/Cho groups. Patients with GBMs in the low Ins/Cho ratio group indicated shorter PFS (P = 0.021) and OS (P = 0.048) than those in the high Ins/Cho group. Multivariate analysis demonstrated that the Ins/Cho ratio was significantly correlated with PFS (hazard ratio 0.24, P = 0.028). In conclusion, the preoperative Ins/Cho ratio can be used as a novel potential prognostic factor for GBM, IDH-wild-type.
  • Shunsuke Nakae, Masanobu Kumon, Kazuhiro Murayama, Shigeo Ohba, Hikaru Sasaki, Joji Inamasu, Kiyonori Kuwahara, Seiji Yamada, Masato Abe, Yuichi Hirose
    Scientific Reports 11(1) 7927-7927 2021年  査読有り筆頭著者責任著者
    <title>Abstract</title>Seizures are common in patients with gliomas; however, the mechanisms of epileptogenesis in gliomas have not been fully understood. This study hypothesized that analyzing quantified metabolites using magnetic resonance spectroscopy (MRS) might provide novel insights to better understand the epileptogenesis in gliomas, and specific metabolites might be indicators of preoperative seizures in gliomas. We retrospectively investigated patient information (gender, age at diagnosis of tumor, their survival time) and tumor information (location, histology, genetic features, and metabolites according to MRS) in patients with gliomas. The data were correlated with the incidence of seizure and analyzed statistically. Of 146 adult supratentorial gliomas, <italic>isocitrate dehydrogenase</italic> (<italic>IDH</italic>) mutant tumors significantly indicated higher incidence of preoperative seizures than <italic>IDH</italic> wild-type gliomas. However, MRS study indicated that glutamate concentration in <italic>IDH</italic> wild-type gliomas was higher than that in <italic>IDH</italic> mutant gliomas. Glutamate was not associated with high frequency of preoperative seizures in patients with gliomas. Instead, increased total <italic>N</italic>-acetyl-<sc>l</sc>-aspartate (tNAA) was significantly associated with them. Moreover, multivariable analysis indicated that increased level of tNAA was an independent predictor of preoperative seizures. According to MRS analysis, tNAA, rather than glutamate, might be a useful to detect preoperative seizures in patient with supratentorial gliomas.
  • Shigeo Ohba, Kazuhiro Murayama, Kiyonori Kuwahara, Eriel Sandika Pareira, Shunsuke Nakae, Yuya Nishiyama, Kazuhide Adachi, Seiji Yamada, Hikaru Sasaki, Naoki Yamamoto, Masato Abe, Joydeep Mukherjee, Mitsuhiro Hasegawa, Russell O Pieper, Yuichi Hirose
    Neurosurgery 87(2) 408-417 2020年8月1日  査読有り
    <title>Abstract</title> <sec> <title>BACKGROUND</title> The extent of resection has been reported to be associated with overall survival in gliomas. The use of 5-aminolevulinic acid (5-ALA) has been recognized to increase the extent of tumor resection. </sec> <sec> <title>OBJECTIVE</title> To evaluate what factors affect the intraoperative fluorescence after administration of 5-ALA in gliomas. </sec> <sec> <title>METHODS</title> Correlation of intraoperative fluorescence and several clinical, radiographic, molecular biologic, and histopathologic characters was retrospectively evaluated in 104 patients (53 males and 51 females; mean age 54.2 yr) with gliomas at our institution. To clarify the mechanisms that mutant isocitrate dehydrogenase (IDH) affect the intraoperative fluorescence, in Vitro experiments using genetically engineered glioma cells harboring mutant IDH1 were performed. </sec> <sec> <title>RESULTS</title> Intraoperative fluorescence was observed in 82 patients (78.8%). In addition to age, magnetic resonance imaging enhancement, World Health Organization grades, and MIB-1 index, the status of IDH was revealed to be correlated with intraoperative fluorescence. In Vitro assay revealed that mutant IDH indirectly reduced the amount of exogenous 5-ALA-derived protoporphyrinogen IX in glioma cells by increasing activity of ferrochelatase and heme oxygenase 1. </sec> <sec> <title>CONCLUSION</title> Mutant IDH1/2-induced metabolite changes of exogenous 5-ALA were suggested to contribute to the lesser intraoperative fluorescence in gliomas with mutant IDH1/2 than in those without. </sec>
  • Joji Inamasu, Kazuhiro Tomiyasu, Masashi Nakatsukasa, Shunsuke Nakae
    International Journal of Stroke 15(1) NP1-NP2 2020年1月  査読有り
  • Sachiko HIRATA, Michiharu MORINO, Shunsuke NAKAE, Takahiro MATSUMOTO
    Neurologia medico-chirurgica 60(1) 17-25 2020年  査読有り
  • Kuwahara K, Ohba S, Nakae S, Hattori N, Pareira ES, Yamada S, Sasaki H, Abe M, Hasegawa M, Hirose Y
    Brain Tumor Pathol. 2019年7月  査読有り
  • Inamasu J, Nakae S, Kato Y, Hirose Y
    Asian J Neurosurg. 2018年10月  査読有り
  • Inamasu J, Nakae S, Kato Y, Hirose Y
    Asian J Neurosurg. 2018年7月  査読有り
  • Shunsuke Nakae, Kazuhiro Murayama, Kazuhide Adachi, Tadashi Kumai, Masato Abe, Yuichi Hirose
    World Neurosurgery 109 197-201 2018年1月1日  査読有り筆頭著者
  • Shigeta Moriya, Shigeo Ohba, Kazuhide Adachi, Yuya Nishiyama, Takuro Hayashi, Shinya Nagahisa, Takafumi Kaito, Shunsuke Nakae, Yuichi Hirose
    Journal of Clinical Neuroscience 47 228-233 2018年1月1日  査読有り
  • 桒原聖典, 石川寛, 平川昭彦, 田中里樹, 若子哲, 大見達夫, 中江俊介, 稲桝丈司, 廣瀬雄一
    神経外傷 2017年12月  査読有り
  • Shunsuke Nakae, Hiroki Uchida, Takeshi Takayanagi, Mitsuhiro Hasegawa, Yuichi Hirose
    CHILDS NERVOUS SYSTEM 33(12) 2077-2078 2017年12月  査読有り筆頭著者責任著者
  • Nakae S, Kato T, Murayama K, Sasaki H, Abe M, Kumon M, Kumai T, Yamashiro K, Inamasu J, Hasegawa M, Kurahashi H, Hirose Y
    Oncotarget. 2017年9月  査読有り筆頭著者
  • Joji Inamasu, Shunsuke Nakae, Kazuhide Adachi, Yuichi Hirose
    BLOOD PRESSURE MONITORING 22(1) 34-39 2017年2月  査読有り
  • Shunsuke Nakae, Kazuhiro Murayama, Hikaru Sasaki, Masanobu Kumon, Yuya Nishiyama, Shigeo Ohba, Kazuhide Adachi, Shinya Nagahisa, Takuro Hayashi, Joji Inamasu, Masato Abe, Mitsuhiro Hasegawa, Yuichi Hirose
    JOURNAL OF NEURO-ONCOLOGY 131(2) 403-412 2017年1月  査読有り筆頭著者
  • Joji Inamasu, Kiyonori Kuwahara, Yushi Kawazoe, Shunsuke Nakae, Yuichi Hirose
    AMERICAN JOURNAL OF EMERGENCY MEDICINE 34(12) 2016年12月  査読有り
  • Joji Inamasu, Shunsuke Nakae, Tatsuo Ohmi, Hirotaka Kogame, Yushi Kawazoe, Tadashi Kumai, Riki Tanaka, Akira Wakako, Kiyonori Kuwahara, Tsukasa Ganaha, Yuichi Hirose
    JOURNAL OF CLINICAL NEUROSCIENCE 33 142-147 2016年11月  査読有り
  • Natsuki Hattori, Yuichi Hirose, Hikaru Sasaki, Shunsuke Nakae, Saeko Hayashi, Shigeo Ohba, Kazuhide Adachi, Takuro Hayashi, Yuya Nishiyama, Mitsuhiro Hasegawa, Masato Abe
    CANCER SCIENCE 107(8) 1159-1164 2016年8月  査読有り
  • Inamasu J, Ishikawa K, Oheda M, Nakae S, Hirose Y, Yoshida S
    J Infect Chemother. 2016年5月  査読有り
  • Joji Inamasu, Akiyo Sadato, Motoki Oheda, Motoharu Hayakawa, Shunsuke Nakae, Tatsuo Ohmi, Kazuhide Adachi, Ichiro Nakahara, Yuichi Hirose
    JOURNAL OF CLINICAL NEUROSCIENCE 27 114-118 2016年5月  査読有り
  • Joji Inamasu, Tsukasa Ganaha, Shunsuke Nakae, Tatsuo Ohmi, Akira Wakako, Riki Tanaka, Kiyonori Kuwahara, Hirotaka Kogame, Yushi Kawazoe, Tadashi Kumai, Motoharu Hayakawa, Yuichi Hirose
    ACTA NEUROCHIRURGICA 158(5) 885-893 2016年5月  査読有り
  • Shunsuke Nakae, Joji Inamasu, Tatsuo Ohmi, Yuichi Hirose
    INTERNAL MEDICINE 55(6) 713-714 2016年  査読有り筆頭著者
  • Natsuki Hattori, Joji Inamasu, Shunsuke Nakae, Yuichi Hirose, Kazuhiro Murayama
    Surgical Neurology International 7(43) S1085-S1088 2016年  査読有り
  • Shunsuke Nakae, Hikaru Sasaki, Saeko Hayashi, Natsuki Hattori, Masanobu Kumon, Yuya Nishiyama, Kazuhide Adachi, Shinya Nagahisa, Takuro Hayashi, Joji Inamasu, Masato Abe, Mitsuhiro Hasegawa, Yuichi Hirose
    PLOS ONE 10(11) 2015年11月  査読有り筆頭著者
  • Motoki Oheda, Joji Inamasu, Shigeta Moriya, Tadashi Kumai, Yushi Kawazoe, Shunsuke Nakae, Yoko Kato, Yuichi Hirose
    JOURNAL OF CLINICAL NEUROSCIENCE 22(8) 1338-1342 2015年8月  査読有り
  • Joji Inamasu, Takeya Watabe, Tsukasa Ganaha, Yasuhiro Yamada, Shunsuke Nakae, Tatsuo Ohmi, Shuei Imizu, Takafumi Kaito, Keisuke Ito, Yuya Nishiyama, Takuro Hayashi, Hirotoshi Sano, Yoko Kato, Yuichi Hirose
    JOURNAL OF CLINICAL NEUROSCIENCE 20(8) 1095-1098 2013年8月  査読有り

講演・口頭発表等

 82

共同研究・競争的資金等の研究課題

 7

学術貢献活動

 1

メディア報道

 2